1-4 of 4
John B. Schnog, MD, PhD
Close
Sort by
Journal Articles

Plasma Concentrations of Asymmetric Dimethylarginine, an Endogenous Nitric Oxide Synthetase Inhibitor, Are Elevated in Sickle Cell Patients but Do Not Increase during Painful Crises.

Pearl Landburg, MD, Tom Teerlink, PhD, Sigrid de Jong, Frits A. Muskiet, PhD, Ashley J. Duits, PhD, John-John B. Schnog, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 3795.
https://doi.org/10.1182/blood.V108.11.3795.3795
Published: 2006
Journal Articles

Vascular Growth Factors in Patients with Sickle Cell Disease.

Ashley J. Duits, PhD, John B. Schnog, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 3787.
https://doi.org/10.1182/blood.V106.11.3787.3787
Published: 2005
Journal Articles

Erythropoietin (EPO) Plasma Levels Reflect the Course of Clinical Vaso-Occlusive Complications in Sickle Cell Disease.

Ashley J. Duits, PhD, Sakir Akin, Erkan Ozveren, Melvin R. Mac Gillavry, MD, PhD, Dees P. Brandjes, MD, PhD, John-John B. Schnog, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 3737.
https://doi.org/10.1182/blood.V104.11.3737.3737
Published: 2004
Journal Articles

ADAMTS13 Activity in Sickle Cell Disease: A Role in the Development of Clinical Vaso-Occlusion?.

John-John B. Schnog, MD, PhD, Johanna Kremer-Hovinga, MD, Sakir Akin, Ernan Ozveren, Soraya Krieg, Bernhard Lammle, MD, PhD, Dees Brandjes, MD, PhD, Melvin R. Mac Gillavry, MD, PhD, Fred D. Muskiet, MD, Ashley J. Duits, PhD
Journal: Blood
Blood (2004) 104 (11): 3738.
https://doi.org/10.1182/blood.V104.11.3738.3738
Published: 2004